Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression

Journal of Autoimmunity

Volumn 55, Issue 1, 2014, Pages 51-62

  Cortés, José R ^a   Sánchez Díaz, Raquel ^a   Bovolenta, Elena R ^a   Barreiro, Olga ^a   Lasarte, Sandra ^a   Matesanz Marín, Adela ^a   Toribio, María L ^b   Sánchez Madrid, Francisco ^a,b   Martín, Pilar ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

CD69; FoxP3; Immune tolerance; Regulatory T cells

Indexed keywords

CD38 ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; DIFFERENTIATION ANTIGEN; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; LECTINS, C-TYPE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84922416591     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.05.007     Document Type: Article

References (44)

1. Akdis C.A., Akdis M. Mechanisms of allergen-specific immunotherapy. JAllergy Clin Immunol 2011, 127:18-27. quiz 8-9.
2. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010, 10:490-500.
3. Barreiro O., Martin P., Gonzalez-Amaro R., Sanchez-Madrid F. Molecular cues guiding inflammatory responses. Cardiovasc Res 2010, 86:174-182.
4. Shiow L.R., Rosen D.B., Brdickova N., Xu Y., An J., Lanier L.L., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.
5. Lopez-Cabrera M., Santis A.G., Fernandez-Ruiz E., Blacher R., Esch F., Sanchez-Mateos P., et al. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. JExp Med 1993, 178:537-547.
6. Testi R., D'Ambrosio D., De Maria R., Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994, 15:479-483.
7. Zingoni A., Palmieri G., Morrone S., Carretero M., Lopez-Botel M., Piccoli M., et al. CD69-triggered ERK activation and functions are negatively regulated by CD94/NKG2-A inhibitory receptor. Eur J Immunol 2000, 30:644-651.
8. Cebrian M., Yague E., Rincon M., Lopez-Botet M., de Landazuri M.O., Sanchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. JExp Med 1988, 168:1621-1637.
9. Martin P., Sanchez-Madrid F. CD69: an unexpected regulator of TH17 cell-driven inflammatory responses. Sci Signal 2011, 4:pe14.
10. Sancho D., Gomez M., Viedma F., Esplugues E., Gordon-Alonso M., Garcia-Lopez M.A., et al. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. JClin Invest 2003, 112:872-882.
11. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
12. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
13. Martin P., Gomez M., Lamana A., Cruz-Adalia A., Ramirez-Huesca M., Ursa M.A., et al. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol Cell Biol 2010, 30:4877-4889.
14. de Heer H.J., Hammad H., Soullie T., Hijdra D., Vos N., Willart M.A., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. JExp Med 2004, 200:89-98.
15. Sancho D., Gomez M., Martinez Del Hoyo G., Lamana A., Esplugues E., Lauzurica P., et al. CD69 targeting differentially affects the course of collagen-induced arthritis. JLeukoc Biol 2006, 80:1233-1241.
16. Burchill M.A., Yang J., Vogtenhuber C., Blazar B.R., Farrar M.A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. JImmunol 2007, 178:280-290.
17. Sebolt-Leopold J.S., Dudley D.T., Herrera R., Van Becelaere K., Wiland A., Gowan R.C., et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors invivo. Nat Med 1999, 5:810-816.
18. Campbell D.J., Koch M.A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011, 11:119-130.
19. Lee J.H., Kang S.G., Kim C.H. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. JImmunol 2007, 178:301-311.
20. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009, 10:595-602.
21. Martin-Gayo E., Sierra-Filardi E., Corbi A.L., Toribio M.L. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010, 115:5366-5375.
22. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory t cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30:531-564.
23. Radulovic K., Manta C., Rossini V., Holzmann K., Kestler H.A., Wegenka U.M., et al. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. JImmunol 2012, 188:2001-2013.
24. Ring S., Enk A.H., Mahnke K. ATP activates regulatory T Cells invivo during contact hypersensitivity reactions. JImmunol 2010, 184:3408-3416.
25. Lieberman S.M., Kim J.S., Corbo-Rodgers E., Kambayashi T., Maltzman J.S., Behrens E.M., et al. Site-specific accumulation of recently activated CD4+ Foxp3+ regulatory T cells following adoptive transfer. Eur J Immunol 2012, 42:1429-1435.
26. Han Y., Guo Q., Zhang M., Chen Z., Cao X. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. JImmunol 2009, 182:111-120.
27. Gandhi R., Farez M.F., Wang Y., Kozoriz D., Quintana F.J., Weiner H.L. Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. JImmunol 2010, 184:4620-4624.
28. Sagoo P., Ali N., Garg G., Nestle F.O., Lechler R.I., Lombardi G. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med 2011, 3:83ra42.
29. Radstake T.R., van Bon L., Broen J., Wenink M., Santegoets K., Deng Y., et al. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS One 2009, 4:e5981.
30. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005, 6:1219-1227.
31. Hill J.A., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
32. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
33. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007, 19:345-354.
34. Haxhinasto S., Mathis D., Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. JExp Med 2008, 205:565-574.
35. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., et al. Tcell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 2008, 105:7797-7802.
36. Gabrysova L., Christensen J.R., Wu X., Kissenpfennig A., Malissen B., O'Garra A. Integrated T-cell receptor and costimulatory signals determine TGF-beta-dependent differentiation and maintenance of Foxp3+ regulatory T cells. Eur J Immunol 2011, 41:1242-1248.
37. Zanin-Zhorov A., Cahalon L., Tal G., Margalit R., Lider O., Cohen I.R. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. JClin Invest 2006, 116:2022-2032.
38. Bilate A.M., Lafaille J.J. Induced CD4(+)Foxp3(+) regulatory t cells in immune tolerance. Annu Rev Immunol 2012, 30:733-758.
39. Martin P., Gomez M., Lamana A., Marin A.M., Cortes J.R., Ramirez-Huesca M., et al. The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. JAllergy Clin Immunol 2010, 126:355-365. 65 e1-3.
40. Mucida D., Kutchukhidze N., Erazo A., Russo M., Lafaille J.J., Curotto de Lafaille M.A. Oral tolerance in the absence of naturally occurring Tregs. JClin Invest 2005, 115:1923-1933.
41. Curotto de Lafaille M.A., Kutchukhidze N., Shen S., Ding Y., Yee H., Lafaille J.J. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008, 29:114-126.
42. Bankovich A.J., Shiow L.R., Cyster J.G. CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. JBiol Chem 2010, 285:22328-22337.
43. Lamana A., Martin P., de la Fuente H., Martinez-Munoz L., Cruz-Adalia A., Ramirez-Huesca M., et al. CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. JInvest Dermatol 2011, 10.1038/jid.2011.54.
44. Liu G., Burns S., Huang G., Boyd K., Proia R.L., Flavell R.A., et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol 2009, 10:769-777.